According to Biocom’s 2019 Economic Impact Report Databook, California is now home to three biotech and pharmaceutical hubs, located in the Bay Area (San Francisco), San Diego, and now Los Angeles. With this in mind, analysis can be completed in the Clinical Trials Database of GlobalData’s Pharma Intelligence Center to find more information and trends for the state of California.

Biopharma clusters

Looking at clinical trial sites in California, it can be seen that the three cities mentioned above are the top three cities for the clinical trial sites (Figure 1). Los Angeles had the most clinical trial sites in California with 11%, followed by San Francisco (6.4%) and San Diego (6.3%). Sacramento and Long Beach rounded out the top five.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Figure 2 shows the trends of clinical trials in California by city. Again, Los Angeles was the top city with 15.2% of all clinical trials in the state of California, San Francisco was second with 8.4% trials, and San Diego was third with 6.8% trials. Sacramento was again fourth with now Stanford rounding out the top five.

As for organisations in the state of California, the Stanford University School of Medicine has the most clinical trials with 2.6% of all clinical trials in the state of California. The University of California San Francisco followed with 2.4% while Kaiser Permanente, USC Norris Comprehensive Cancer Center, and Cedars-Sinai Medical Center all had under 2.0%. This can be seen in Figure 3.